Literature DB >> 11727933

pH and multidrug resistance.

P D Roepe1.   

Abstract

Most chemotherapeutic drugs in use today are hydrophobic small molecules that are also typically either weakly basic, weakly acidic or charged. Thus, changes in the electrochemical parameters of tumour cell membranes have important effects on their transmembranous diffusion and cellular retention. Changes in these parameters can also modulate the function of immunological agents, and affect the signal transduction associated with induction of apoptosis. For these reasons, it is logical to propose that many (if not most) of the characteristics of multidrug-resistant (MDR) tumour cells could be due to perturbations in cellular ion transport. Indeed, many reports of altered ion transport in MDR cells can be found in the literature. Moreover, many studies suggest that P glycoprotein (Pgp) overexpression confers this altered ion transport, however, detailed physical-chemical analysis of this phenomenon has been confused by the complexity of the model systems devised to study Pgp. To help resolve this confusion, our laboratory has focused on a detailed characterization of 'pure' and stable Pgp transfectants unadulterated by the complications of chemotherapeutic drug exposure, various yeast strains and yeast vesicle preparations, and purified, reconstituted Pgp preparations. Recent data obtained with these model systems are summarized in this paper.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727933     DOI: 10.1002/0470868716.ch16

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  8 in total

1.  Effect of mitogen-activated protein kinase signal transduction pathway on multidrug resistance induced by vincristine in gastric cancer cell line MGC803.

Authors:  Bo Chen; Feng Jin; Ping Lu; Xiang-Lan Lu; Ping-Ping Wang; Yun-Peng Liu; Fan Yao; Shu-Bao Wang
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

2.  Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines.

Authors:  Ying Han; Zhe-Yi Han; Xin-Min Zhou; Ru Shi; Yue Zheng; Yong-Quan Shi; Ji-Yan Miao; Bo-Rong Pan; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Importance of the difference in surface pressures of the cell membrane in doxorubicin resistant cells that do not express Pgp and ABCG2.

Authors:  Charlotte Bell; Claire Hill; Christopher Burton; Adam Blanchard; Freya Shephard; Cyril Rauch
Journal:  Cell Biochem Biophys       Date:  2013-07       Impact factor: 2.194

Review 4.  Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies.

Authors:  Salvador Harguindey; Julian Polo Orozco; Khalid O Alfarouk; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2019-09-01       Impact factor: 5.923

Review 5.  Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR in Candida albicans.

Authors:  Saif Hameed; Zeeshan Fatima
Journal:  Int J Microbiol       Date:  2013-09-16

6.  Proton pump inhibitors for the treatment of cancer in companion animals.

Authors:  Megan Walsh; Stefano Fais; Enrico Pierluigi Spugnini; Salvador Harguindey; Tareq Abu Izneid; Licia Scacco; Paula Williams; Cinzia Allegrucci; Cyril Rauch; Ziad Omran
Journal:  J Exp Clin Cancer Res       Date:  2015-09-04

Review 7.  A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Kevin Hardonniere; Daniel Stanciu; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

Review 8.  Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.